Supply Chain
Long wait times, crowded waiting rooms, and frustrated staff are often symptoms of inefficient workflows driven by physical space constraints.…
Lawmakers are calling on the Department of Veterans Affairs to pay medical device companies up to $15 million in late payments for implants and devices used in VA hospitals, reports The Journal Gazette.
The Food and Drug Administration on Tuesday published a list of brand name drugs without generic competition and implemented a policy to accelerate generic drug approvals.
The Food and Drug Administration has approved five biosimilars since 2010 — none of which are designated as "interchangeable" to the biologic drug they mimic, reports Regulatory Focus.
Two drug companies that use or repackage Hospira products launched secondary recalls in response to the drugmaker's June 15 recall of several injectable drugs.
Hill-Rom Holdings will sell its German hospital bed business, Völker, to a CoBE Capital affiliate.
An internal technical issue put Medtronic's computer system offline for nearly a week, disrupting the devicemaker's global supply chain, reports StarTribune.
The Food and Drug Administration granted premarket approval to Thermo Fisher Scientifics' lung cancer biomarker sequencing test.
The Food and Drug Administration on Friday approved Portola Pharmaceuticals' oral blood thinner, betrixaban, reports Reuters.
GlaxoSmithKline will cease production of its seizure drug, Potiga, in mid-2017 due to low patient demand, reports Fox 61.
Regulatory leaders should make better use of available data during postapproval monitoring of medical devices, two researchers from the Ann Arbor-based University of Michigan Center for Healthcare Outcomes and Policy wrote in a JAMA analysis.